17-51154262-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_198175.1(NME1):c.-112C>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.387 in 945,918 control chromosomes in the GnomAD database, including 71,543 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.39 ( 11172 hom., cov: 30)
Exomes 𝑓: 0.39 ( 60371 hom. )
Consequence
NME1
NM_198175.1 5_prime_UTR
NM_198175.1 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.19
Genes affected
NME1-NME2 (HGNC:33531): (NME1-NME2 readthrough) This locus represents naturally occurring read-through transcription between the neighboring NME1 and NME2 genes. The significance of this read-through transcription and the function of the resulting protein product have not yet been determined. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Nov 2010]
NME1 (HGNC:7849): (NME/NM23 nucleoside diphosphate kinase 1) This gene (NME1) was identified because of its reduced mRNA transcript levels in highly metastatic cells. Nucleoside diphosphate kinase (NDK) exists as a hexamer composed of 'A' (encoded by this gene) and 'B' (encoded by NME2) isoforms. Mutations in this gene have been identified in aggressive neuroblastomas. Two transcript variants encoding different isoforms have been found for this gene. Co-transcription of this gene and the neighboring downstream gene (NME2) generates naturally-occurring transcripts (NME1-NME2), which encodes a fusion protein comprised of sequence sharing identity with each individual gene product. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 17-51154262-C-G is Benign according to our data. Variant chr17-51154262-C-G is described in ClinVar as [Benign]. Clinvar id is 2688272.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.397 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NME1 | NM_000269.3 | c.-5+600C>G | intron_variant | ENST00000393196.8 | NP_000260.1 | |||
NME1 | NM_198175.1 | c.-112C>G | 5_prime_UTR_variant | 2/6 | NP_937818.1 | |||
NME1-NME2 | NM_001018136.3 | c.-5+600C>G | intron_variant | NP_001018146.1 | ||||
NME1-NME2 | NR_037149.2 | n.142C>G | non_coding_transcript_exon_variant | 2/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NME1-NME2 | ENST00000555572 | c.-112C>G | 5_prime_UTR_variant | 2/9 | 2 | ENSP00000451932.1 | ||||
NME1 | ENST00000393196.8 | c.-5+600C>G | intron_variant | 1 | NM_000269.3 | ENSP00000376892.3 |
Frequencies
GnomAD3 genomes AF: 0.385 AC: 58267AN: 151184Hom.: 11155 Cov.: 30
GnomAD3 genomes
AF:
AC:
58267
AN:
151184
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.387 AC: 307602AN: 794614Hom.: 60371 Cov.: 11 AF XY: 0.383 AC XY: 161395AN XY: 421316
GnomAD4 exome
AF:
AC:
307602
AN:
794614
Hom.:
Cov.:
11
AF XY:
AC XY:
161395
AN XY:
421316
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.385 AC: 58322AN: 151304Hom.: 11172 Cov.: 30 AF XY: 0.381 AC XY: 28169AN XY: 73864
GnomAD4 genome
AF:
AC:
58322
AN:
151304
Hom.:
Cov.:
30
AF XY:
AC XY:
28169
AN XY:
73864
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1246
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 27% of patients studied by a panel of primary immunodeficiencies. Number of patients: 26. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at